Detailed Information on Publication Record
2009
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
LUDWIG, Heinz, Roman HÁJEK, Elena TÓTHOVÁ, Johannes DRACH, Zdeněk ADAM et. al.Basic information
Original name
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
Name in Czech
Srovnání léčby Thalidomid-dexamethason s melphalan-prednison u pacientů s mnohočetným myelomem
Authors
LUDWIG, Heinz (40 Austria), Roman HÁJEK (203 Czech Republic, guarantor), Elena TÓTHOVÁ (703 Slovakia), Johannes DRACH (40 Austria), Zdeněk ADAM (203 Czech Republic), Boris LABAR (191 Croatia), Miklós EGYED (348 Hungary), Ivan ŠPIČKA (203 Czech Republic), Heinz GISSLINGER (40 Austria), Richard GREIL (40 Austria), Ingrid KUHN (40 Austria), Niklas ZOJER (40 Austria) and Axel HINKE (276 Germany)
Edition
Blood, Washington, DC, USA, The American Society of Hematology, 2009, 0006-4971
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30200 3.2 Clinical medicine
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 10.555
RIV identification code
RIV/00216224:14110/09:00035390
Organization unit
Faculty of Medicine
UT WoS
000265052300008
Keywords (in Czech)
mnohočetný myelom; thalidomid
Keywords in English
multiple myeloma; thalidomide; dexamethasone; melphalane; prednisone
Tags
International impact, Reviewed
Změněno: 1/4/2010 16:54, Mgr. Anna Potáčová, Ph.D.
V originále
We compared thalidomide-dexamethasone with melphalan-prednisolone in 289 elderly patients with multiple myeloma. This is the first trial to compare TD with MP in elderly patients. Results in the TD group showed a significantly higher rate of very good responses (CR and VGPR) and significantly shorter time to response with no difference in time to progression and in progression-free survival.
In Czech
V článku je dokumentován výsledek první srovnávací studie léčby thalidomid-dexamethason s léčbou melphalan-prednisone.
Links
| LC06027, research and development project |
| ||
| MSM0021622434, plan (intention) |
|